Your directors have the pleasure of presenting the thirty-third annual report of your Company togetherwith the audited financial statements for the financial year ended 31st March 2025.
1. a. FINANCIAL SUMMARY OR HIGHLIGHTS OR THE PERFORMANCE OF THECOMPANY (? in Lacs)
Particulars
Standalone
Consolidated
2024-25
2023-24
Total Income
25294.61
19342.01
Profit before Deprecation,Finance Cost, Tax andExceptional items
2611.03
2226.28
2616.09
Depreciation and amortizationexpenses
520.92
429.13
Finance cost
486.97
415.90
419.79
Exceptional Items
NIL
Profit before Tax
1603.15
1381.25
1675.39
Less: Tax expenses
428.05
311.08
442.13
Profit for the year
1175.10
1070.17
1233.26
Other comprehensive incomefor the year
(38.39)
(4.66)
Total comprehensive incomefor the year
1136.71
1065.51
1194.87
b. DIVIDEND
Your directors do not recommend payment of dividend on equity shares.
c. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION ANDPROTECTION FUND
The provisions of Section 125(2) of The Companies Act, 2013 do not apply as there was nodividend declared and paid in the last seven years.
d. MATERIAL CHANGES AND COMMITMENT IF ANY AFFECTING THEFINANCIAL POSITION OF THE COMPANY OCCURRED BETWEEN THE ENDSOF THE FINANCIAL YEAR TO WHICH THIS FINANCIAL STATEMENT RELATEAND THE DATE OF THE REPORT
No such material changes occurred, which affected the financial position of the company.
e. SHARE CAPITAL
The paid-up capital of the company as on 31st March 2025 was INR 8 Crore. During the yearunder review the Company has not altered its share capital, consequently there has been nochange in the capital structure since previous year.
f. DETAILS OF POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANYON ITS CORPORATE SOCIAL RESPONSIBILITY INITIATIVES
As per the rule of the Companies Act, 2013 CSR is applicable on our company, and theCompany has made an annual CSR contribution of Rs. 22 Lakhs to Rukmani Devi SharadhaTrust for Rural Development Projects and Hari Om Trust for medical camp in Uttarkhand.
2. MANAGEMENT DISCUSSION AND ANALYSIS
Management Discussion and Analysis of financial condition and of operations of the Companyfor the year under review as required under Regulation 34 of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 with the Stock Exchanges is given in the part onCorporate Governance elsewhere in the Annual Report marked as “Annexure A”.
3. FINANCE
3.1. PUBLIC DEPOSIT
The Company has not accepted any deposit falling within the ambit of Section 73 of theCompanies Act, 2013 read with The Companies (Acceptance of Deposits) Rules, 2014.
3.2. PARTICULARS OF LOAN AND INVESTMENT AND GUARANTEE SECURITY
The company has not given any loan under this section except making investments in, givingloans and guarantees to and providing securities in connection with loans to its whollyowned subsidiaries from time to time, in compliance with the applicable provisions of theAct.
4. INTERNAL FINANCIAL CONTROL
The Company has formulated and implemented comprehensive guidelines to establish andmaintain robust internal financial controls. These controls are embedded across variouslevels of operations and encompass both manual processes and automated systems,including Enterprise Resource Planning (ERP) applications. The ERP systems areconfigured to ensure that all financial transactions are appropriately authorized, accuratelyrecorded, and systematically reported. These controls are tailored to suit the specific natureof operations conducted at different business locations and across various functionaldomains, thereby ensuring relevance and effectiveness in internal governance.
The framework is designed to provide reasonable assurance regarding the reliability offinancial reporting, safeguarding of assets, prevention and detection of frauds and errors,accuracy and completeness of accounting records, and timely preparation of financialstatements.
To ensure the adequacy and operational effectiveness of these internal financial controls,periodic evaluations are conducted. The Internal Auditors carry out detailed assessments aspart of their audit plan, and their findings are regularly reviewed by the management andthe Audit Committee. In addition, the Statutory Auditors independently evaluate the internalfinancial controls over financial reporting as part of their audit procedures.
5. SUBSIDIARY COMPANY, JOINT VENTURE & ASSOCIATE COMPANY
As on 31st March 2025 your Company has 7 Wholly owned Subsidiary Companies: -
a) Yocnex Chemicals Private Limited
b) Suksess Chemicals Private Limited
c) Nocnex Chemicals Private Limited
d) Ocilim Advisory Services Private Limited
e) Wide Range Merchants Private Limited
f) Allied Maritime & Infra Engineering Private Limited
g) ARCL Petrochemicals Limited
In Compliance with IND AS-110, your Company has prepared its consolidated financialstatements which forms part of its Annual Report. Pursuant to the provisions of Section129(3) of Companies Act, 2013, the salient features of the subsidiary Company in theprescribed form AOC-1 is a part of the consolidated financial statements.
Your Company does not have any associates, holding or joint ventures as on 31st March,2025.
6. YEAR IN RETROSPECT AND FUTURE OUTLOOK:
The specialty chemicals and broader chemicals industry serve as the backbone of multiplesectors, including agriculture, construction, automotive, electronics, pharmaceuticals, textiles,and consumer goods. In FY 2023-24, the global industry faced a complex environment shapedby macroeconomic uncertainty, geopolitical tensions, shifting supply chains, and growingregulatory and sustainability demands. Nevertheless, resilience in end-use markets, innovation-led growth, and increased focus on specialty products continued to offer new avenues forexpansion.
The global specialty chemicals market was valued at approximately USD 820 billion in 2023,with an annual growth rate of 4.8%. The broader chemicals market exceeded USD 5 trillion,driven by steady demand from infrastructure, agriculture, personal care, and electronics sectors.Despite supply chain disruptions, inflationary pressures, and energy cost volatility—especiallyin Europe—key markets such as Asia-Pacific and North America remained stable.
Asia-Pacific retained its dominance, accounting for over 45% of global specialty chemicalconsumption. China and India emerged as pivotal players due to increased domestic demand,export opportunities, and government support for chemical manufacturing clusters.
Europe experienced slow growth owing to energy crises and regulatory constraints but remaineda hub for green chemistry and innovation.
North America benefited from onshoring trends, energy availability, and increased productionof high-value specialty chemicals, particularly in the U.S.
Global chemical players continued shifting from commoditized products to higher-margin,innovation-led specialty chemicals. This shift not only improved financial performance but alsoreduced environmental risks and strengthened customer relationships through customization.Outlook for FY 2024-25
a. Growth Projections
The specialty chemicals industry is projected to grow at a CAGR of 5.5%, reaching USD 870¬900 billion by FY 2025. The broader chemicals market is expected to cross USD 5.5 trillion,supported by post-COVID recovery in infrastructure, automotive, and industrial manufacturing.
b. Emerging Markets and India’s Role
India is expected to be a standout performer due to:
India's specialty chemicals industry is expected to grow at over 11-12% CAGR, potentiallyreaching USD 65-70 billion by 2025.
Equity shares of the Company got listed on 29th September 2023 on BSE and the listing Feesfor the Financial year 2025 - 2026 have been paid on 30.04.2025 and 72.44% of the EquityShare Capital of the Company is in Dematerialization form.
(a) In the preparation of the Annual Accounts the applicable accounting standards have beenfollowed along with proper explanation relating to material departures.
(b) The directors have selected such accounting policies and applied them consistently andmade judgment and estimates that are reasonable and prudent so as to give a true and fairview of the state of affairs of the company at the end of the financial year and the profit andloss of the company for that period.
(c) The directors have taken proper and sufficient care for the maintenance of adequateaccounting records in accordance with the provision of this act for safeguarding the assets ofthe company and for preventing and detecting fraud and other irregularities.
(d) The directors have prepared the annual accounts on a going concern basis.
(e) The directors, have laid down internal financial control to be followed by the companyand that such internal financial control are adequate and were operating effectively, and
(f) The directors have devised proper systems to ensure compliance with the provision of allapplicable laws and that such system were adequate and operating effectively.
There are no materially significant related party transactions made by the Company withPromoters, Directors, Key Managerial Personnel or other designated persons which mayhave a potential conflict with the interest of the Company at large.
All Related Party Transactions are placed before the Audit Committee as also the Board forapproval. Prior omnibus approval of the Audit Committee is obtained on a yearly basis forthe transactions which are foreseen and are of repetitive nature. The transactions entered intopursuant to the omnibus approval so granted are of audited and a statement giving details ofall related party transactions is placed before the Audit Committee and the Board of Directorsfor their approval on a yearly basis. The policy on Related Party Transactions as approvedby the Board is uploaded on the Company’s website www .arclorganics.com.
The Company has a Vigil Mechanism to deal with instance of fraud and mismanagement, ifany. The details of the Vigil Mechanism is explained in the Corporate Governance Reportand also posted on the website of the Company www.arclorganics.com.
ARCL Organics Ltd is committed to upholding the highest standards of corporategovernance. The principles of good governance are deeply embedded in the Company’sculture and extend to all stakeholders, influencing every business decision. The Companyplaces paramount importance on accuracy in financial reporting, integrity, transparency,legal compliance in both letter and spirit, and the empowerment of individuals at all levels.The Management Discussion and Analysis Report is presented under the section titled "TheYear in Review" in the Annual Report. Additionally, the Corporate Governance Report,along with a Certificate from the Secretarial Auditors affirming compliance with theprescribed corporate governance norms, is annexed and forms an integral part of theDirectors’ Report.
The Company makes a conscious and continuous effort to ensure that the core valuesarticulated in the Codes of Conduct for Directors, Senior Management Personnel, andEmployees are upheld across the organization. These values are not only documented but arealso practiced in spirit, fostering a culture of accountability, ethical conduct, and responsibleleadership at all levels.
Pursuant to section 92(3) read with section 134(3)(a) of the Act, the Annual Return as on 31stMarch 2024 may be accessed on the Company's website at the www.arclorganics.com.
In accordance with The Sexual Harassment of Women at Workplace (Prevention, Prohibitionand Redressal) Act, 2013 to provide for the effective enforcement of the basic human rightof gender equality and guarantee against sexual harassment and abuse, more particularlyagainst sexual harassment at work place, your Company has a Policy on Prevention of SexualHarassment at the Workplace duly approved by the Board of Directors and posted on thewebsite of the Company www.arclorganics.com.
During the year, no complaint was reported under The Sexual Harassment of Women atWorkplace (Prevention, Prohibition and Redressal) Act, 2013.
Particulars required under Section 134(3)(m) of the Act, read with Rule 8 of the Companies(Accounts) Rules, 2014, under the heads (a) conservation of energy; and (b) technologyabsorption, are not applicable to the Company. During the year there was no foreignexchange earnings (previous year nil). Foreign Exchange outgo during the year aggregatedto Nil. (previous year Nil).
Composition of the Board of Directors of your Company fulfills the criteria fixed byRegulation 17 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 with fifty per cent of the Directors being Non-Executive Director with atleast one-women independent director. Your Board comprises of (Six) directors out of which3 (Three) are independent directors and it includes one-woman independent director.
Mr. Rajesh Mundhra is Executive Director, retires by rotation in accordance with therequirements of Companies Act, 2013 and Articles of Association of the Company. He beingeligible offers himself for re-appointment.
Brief resume of Mr. Rajesh Mundhra, nature of his expertise in specific functional areas,names of companies in which he holds directorships and/or memberships/chairmanships ofcommittees of Board, his shareholdings are furnished in section on “CorporateGovernance” elsewhere in the Annual Report.
Further, as declared by them, none of the Directors of the Company is disqualified from beingappointed as a Director, as specified in section 164(2) of the Companies Act, 2013 and rule14(1) of the Companies (Appointment and Qualification of Directors) Rules 2014 or isdebarred or disqualified from being appointed or continuing as Director of companies by theSEBI/Ministry of Corporate Affairs or any such statutory authority.
All Independent Directors have given declarations that they meet the criteria of independenceas laid down under Section 149(6) of the Companies Act, 2013 and SEBI (ListingObligations and Disclosure Requirements) Regulations, 2015.
Pursuant to the provisions of the Companies Act, 2013 and SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015, the Board has carried out an annualperformance evaluation of its own performance, the directors individually, Key ManagerialPersonnel (KMP), Senior Management as well as the evaluation of the working of its Audit
Committee, Nomination & Remuneration Committee and Stakeholders RelationshipCommittee. The manner in which the evaluation has been carried out has been explained inthe Corporate Governance Report.
16.2. NOMINATION & REMUNERATION POLICY
The Board has, on the recommendation of the Nomination & Remuneration Committeeframed a policy for selection and appointment of Directors, Senior Management and theirremuneration the contents of which are placed on the website of the Company atwww.arclorganics.com.
16.3. MEETINGS
During the year four (04) Board Meetings and Four (04) Audit Committee Meetings wereconvened and held, the details of which are given in the “Corporate Governance Report”.The intervening gap between the Meetings was within the period prescribed under theCompanies Act, 2013.
17. AUDITORS
17.1. STATUTORY AUDITORS
The Member had appointed M/s L. B. Jha & Co, Chartered Accountants (Firm RegistrationNo 301088E) as the statutory auditor of the Company at the 31st Annual General Meeting, tohold office as such, for a term of 5 years till the conclusion of 36th Annual General Meeting.M/s L.B. Jha & Co. continues to be the auditor of the Company for the financial year 2024 -2025.
The observations made in the Auditor’s Report are self-explanatory and therefore, do not callfor any further comments under Section 134(3)(f) of the Act.
17.2. SECRETARIAL AUDIT
Pursuant to the provisions of Section 204 of the Companies Act, 2013 and The Companies(Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Company hadappointed M/s. KSN & Co, Company Secretary in Practice to undertake the Secretarial Auditof the Company. The Secretarial Audit Report is annexed herewith as “Annexure B”.
There are no qualifications. Qualifications contained in the Auditors’ Report if any have beendealt with in the Notes to financial statements and are self-explanatory.
There are no qualifications. Qualifications contained in the Secretarial Auditors’ Report ifany have been dealt with in the Notes to Form MR-3 and are self-explanatory.
During the year under review, the Auditors have not reported any matter under Section 143(12) of the Act, therefore no detail is required to be disclosed under Section 134 (3) (ca) ofthe Act.
Pursuant to section 148 of the Act, the Board has appointed M/s. Amit Khetan & Co (FirmRegistration No. - 102559), to conduct the audit of cost records of the Company for theFinancial Year 2024 - 2025.
Pursuant to Section 204 of the Act and the Companies (Appointment and Remuneration ofManagerial Personnel) Rules, 2014, the Board had appointed M/s KSN & Co., PracticingCompany Secretaries, to conduct Secretarial Audit of the Company for the Financial year2024 - 2025.
The Secretarial Audit Report for the Financial year 2024 - 2025 is provided as an Annexureto this Report. The Report does not contain any qualification, reservation or adverse remark.
The Company has undertaken an audit for the Financial Year ended March 31, 2025, for allapplicable compliances as per the Securities and Exchange Board of India Regulations andCirculars/Guidelines issued thereunder. The Annual Secretarial Compliance Report issuedby M/s KSN & Co., Practicing Company Secretaries, has been submitted to the StockExchanges on 29.05.2025 which is within 60 days from the end of the Financial Year.
The Board of Directors of the Company has appointed M/s. MIB & Co. as Internal Auditorsto carry out extensive Internal Audit of the Company for the Financial Year ended March 31,2025.
During the year under the review the Statutory Auditor, Secretarial Auditor, Cost Auditorand Internal Auditor has not reported any instances of fraud committed in the company byits directors or officers or employees to the Audit Committee under section 143(12) of theCompanies Act, 2013.
The information required pursuant to Section 197 read with Rule 5 of The Companies(Appointment and Remuneration of Managerial Personnel) Rules, 2014 in respect ofemployees of the Company, is given in “Annexure C”.
Your Company has contributed Rs.35,84,83,617/-to the Central and State Exchequer by wayof Taxes and duties.
Information as required under section 134(3)(m) of the companies act 2013 read with Rule8(3) of Companies (Accounts) rules, 2014):
a. Energy Conservation Measures Taken:
• Improvisation and continuous monitoring of Power Factor and replacement of weak capacitorsby conducting periodical checking of capacitors.
• Installation of isolating valve in main airline for preventing air loss.
• The Company has relentlessly aimed at optimising the use of energy resources and takenadequate measures to avoid wastage and use latest technology and equipments.
• Opportunity to compete in International Markets
• Technology up-gradation
• Development of new designs in products
• Attaining accreditation of our products from Internationally recognized Organizations
• Power & Fuel Consumption
I.
Electricity
Values
Purchased Units (KWH in lacs)
86.90
Total Amount (in Lacs)
726.79
Monthly average (Rs. In Lacs)
60.56
Rate (Rs/KWH)
8
II
Fuel Consumption
LDO Consumption (in KL)
203.29
Total Amount (Rs. In Lacs)
119.56
Monthly average (Rs. Lacs)
9.96
Rate (Rs/Lacs)
58.81
FO Consumption from April 2024 to March 2025 = 109.85KLTotal amount (Rs in Lacs) = 66.21Monthly Average (Rs in Lacs) = 5.52Rate (Rs/Litre) = 60.28
Research and Development (R & D):
The current success, and our future success, is largely dependent on our ability to develop newproducts and processes and to improve the features of existing products. The research activityincludes-
a) Low emission formaldehyde E0/E1 in plywood application.
b) Slow Release Nitrogen crude protein in cattle field application, M PRO.
c) Import Substitution cross linker HMMM.
Expenditure on R & D:
No.
2024-25 (Rs.)
Capital Expenses
5,32,100
II.
Revenue Expenses
1,11,42,664
III.
Total
1,16,74,764
It’s a matter of great pride that company got recognition by Government of India approving ourin-house laboratory as DSIR certified. There are many funds received from all over the worldwith Government of India for R&D works. They gave these funds to DSIR recognizedlaboratory only. This will give us an opportunity to get such funds and do real great R&D,helping world and society with innovations. We are pretty sure under the leadership of our
talented R&D chief, ARCL will achieve lot of recognition & do real innovativeresearch benefiting the industry & society.
Foreign Exchange Earnings and Outgo:
a) Expenditure in Foreign Currency - Rs. 40,83,456/-
b) Earnings in Foreign Currency- Rs. 72,43,08,259/-
Secured
Loan
Excluding
Deposits
Unsecured
Loans
Indebtedness
Indebtness at the beginning of the financial year
i) Principal Amount
804.42
2082.62
-
2887.04
ii) Interest due but notpaid
iii) Interest accrued butnot due
Total (i ii iii)
Change in Indebtedness during the financial year
Additions
950.96
730.52
1681.48
Reduction
697.54
361.36
1058.90
Net Change
253.42
369.16
622.58
Indebtedness at the end ofthe financial year
1057.84
2451.78
3509.62
28. MATERNITY BENEFIT
The Company continues to comply with the provisions of the Maternity Benefit Act, 1961.Eligible female employees are provided maternity leave and benefits as per statutory norms.Maternity leave of up to 26 weeks is granted for the first two children and 12 weeks forsubsequent childbirths, along with full pay during the leave period. The Company remainscommitted to supporting the health and well-being of its employees and fostering a conducivework environment for working mothers.
29. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS ORCOURTS
There is no significant material orders passed by the Regulators/Courts which would impactthe going concern status of the Company and its future operation.
30. ACKNOWLEDGEMENTS
Your directors express their sincere appreciation of the co-operation and assistance receivedfrom the shareholders, bankers, regulatory bodies and other business constituents during theyear under review.
Regd. Office:
Rampur Budge Budge Trunk Road,
Kolkata 700 14113th Day of May 2025
For and on behalf of the Board of Directors
Suraj Ratan MundhraChairman and Managing Director(DIN No. 00681223)